14400 Participants Needed

Enhanced Hearing Screening + Telemedicine Referral for Childhood Hearing Loss

SR
SE
Overseen BySusan Emmett, MD, MPH
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Arkansas
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This trial will evaluate a multilevel intervention (STAR model) that combines mobile health (mHealth) hearing screening tools with telemedicine technology for specialty care access in rural Kentucky schools. An initial version of the model was used in rural Alaska where telemedicine-based specialty referral improved both proportion of children receiving follow-up and time to follow-up. The refined STAR model will utilize an enhanced mHealth screening protocol that includes tympanometry for the detection of middle ear disease. The STAR model will also include a specialty telemedicine referral process in schools for children who refer school screening.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the treatment Enhanced Hearing Screening + Telemedicine Referral for Childhood Hearing Loss?

Research shows that using telemedicine for ear screening in Indigenous communities in Queensland effectively identified children at risk of hearing impairment, leading to timely specialist referrals and improved access to care. Additionally, mobile health screening and telemedicine referrals in rural Alaska improved follow-up times for school hearing screenings, suggesting that similar approaches can enhance access to specialty care for childhood hearing loss.12345

Is the Enhanced Hearing Screening + Telemedicine Referral for Childhood Hearing Loss safe for children?

The available research on mobile health and telemedicine-based hearing screening programs, including those using tablets and smartphones, suggests they are generally safe for children. These programs have been effectively used in various communities to screen for hearing issues without reported safety concerns.13678

How is the Enhanced mHealth Screening treatment different from other treatments for childhood hearing loss?

The Enhanced mHealth Screening treatment is unique because it uses mobile health technology and telemedicine to screen and refer children for hearing loss, allowing specialists to assess children remotely and improving access to care, especially in rural or underserved areas. This approach is different from traditional methods that require in-person visits and may not be as accessible for all children.123910

Research Team

MB

Matt Bush, MD, PhD

Principal Investigator

University of Kentucky

SE

Susan Emmett, MD, MPH

Principal Investigator

University of Arkansas Medical Sciences

Eligibility Criteria

This trial is for children entering elementary school in one of the 14 participating counties in rural Kentucky. It's open to all kids, no matter their age, gender, race, or ethnicity. There are no specific exclusion criteria mentioned.

Inclusion Criteria

My eligibility is not limited by my age, gender, race, or ethnicity.
Enrolled in school in one of the 14 participating counties
Initial entry into elementary school

Exclusion Criteria

N/A

Timeline

Screening

Participants are screened for eligibility to participate in the trial

4 years
Annual school-based screening

Control Period

Standard hearing screening and referral process in place before intervention

1-2 years

Enhanced mHealth Screening

Implementation of enhanced mHealth screening protocol including tympanometry

1-2 years

Specialty Telemedicine Referral

Addition of telemedicine referral process to enhanced screening protocol

1-2 years

Follow-up

Participants are monitored for follow-up after screening and referral

Up to 60 days from the date of screening

Treatment Details

Interventions

  • Enhanced mHealth Screening
  • Specialty Telemedicine Referral
  • Standard School Screening and Referral
Trial OverviewThe study tests a new approach (STAR model) that uses mobile health tools and telemedicine to improve hearing loss screening and follow-up care in rural schools. It includes an enhanced mHealth screening with tympanometry and a specialty telemedicine referral process.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Sequence 2Experimental Treatment3 Interventions
Standard Hearing Screening: All counties in Sequence 2 will receive standard hearing screening in the control period, Years 1 and 2 Standard Referral: All counties in Sequence 2 will receive standard referral in control period, Years 1, 2 and 3. Enhanced mHealth screening component: Counties randomized to Sequence 2 will receive the enhanced mHealth screening in Years 3 and 4. Specialty telemedicine referral component: Counties randomized to Sequence 2 will receive the specialty telemedicine referral component in addition to the enhanced mHealth screening in Year 4.
Group II: Sequence 1Experimental Treatment3 Interventions
Standard School Screening: All counties in Sequence 1 will receive standard hearing screening in the control period, Year 1 Standard Referral: All counties in Sequence 1 will receive standard referral in control period, Years 1 and 2. Enhanced mHealth screening component: Counties randomized to Sequence 1 will receive the enhanced mHealth screening in Years 2, 3, and 4. Specialty telemedicine referral component: Counties randomized to Sequence 1 will receive the specialty telemedicine referral component in addition to the enhanced mHealth screening in Years 3 and 4.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Arkansas

Lead Sponsor

Trials
500
Recruited
153,000+

Duke University

Collaborator

Trials
2,495
Recruited
5,912,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

University of Kentucky

Collaborator

Trials
198
Recruited
224,000+

Findings from Research

The mobile ear-screening service in an Aboriginal community successfully screened 1053 children over three years, achieving an impressive average screening rate of 85%.
More than half of the assessments led to referrals for further evaluation or treatment, demonstrating the effectiveness of telemedicine in connecting local health workers with specialist ENT care for children at risk of hearing impairment.
A mobile telemedicine-enabled ear screening service for Indigenous children in Queensland: activity and outcomes in the first three years.Smith, AC., Armfield, NR., Wu, WI., et al.[2022]
The UK has transitioned from using the ineffective infant distraction test for hearing loss screening to implementing a national newborn hearing screening program (NHSP), which is based on more advanced technology and aims for early detection of hearing issues.
The NHSP is expected to improve early identification and intervention for permanent congenital childhood hearing loss, although challenges remain regarding the management of late-onset and temporary hearing losses, as well as the effectiveness of screening for milder cases.
Screening for hearing loss in childhood: issues, evidence and current approaches in the UK.Bamford, J., Uus, K., Davis, A.[2016]
In a study involving 1481 children from 15 rural Alaskan communities, telemedicine specialty referral significantly reduced the time to follow-up after positive hearing screenings, with an average of 41.5 days compared to 92.0 days for standard primary care referrals.
The telemedicine approach also resulted in a higher follow-up rate, with 68.5% of children receiving follow-up care compared to only 32.1% in the primary care group, demonstrating its effectiveness in improving access to necessary healthcare services for rural children.
Mobile health school screening and telemedicine referral to improve access to specialty care in rural Alaska: a cluster- randomised controlled trial.Emmett, SD., Platt, A., Turner, EL., et al.[2023]

References

A mobile telemedicine-enabled ear screening service for Indigenous children in Queensland: activity and outcomes in the first three years. [2022]
Screening for hearing loss in childhood: issues, evidence and current approaches in the UK. [2016]
Mobile health school screening and telemedicine referral to improve access to specialty care in rural Alaska: a cluster- randomised controlled trial. [2023]
Monitoring ear health through a telemedicine-supported health screening service in Queensland. [2022]
Childhood hearing loss detected beyond the newborn screen. [2023]
Mhealth hearing screening for children by non-specialist health workers in communities. [2021]
Tablet-Based Hearing Screening Test. [2018]
Evaluation of a game-based hearing screening program for identifying hearing loss in primary school-aged children. [2023]
Improving the access of young urban children to speech, language and hearing screening via telehealth. [2011]
The use of telehealth services to facilitate audiological management for children: A scoping review and content analysis. [2018]